» Articles » PMID: 31821027

Non-invasive Imaging of High-risk Coronary Plaque: the Role of Computed Tomography and Positron Emission Tomography

Overview
Journal Br J Radiol
Specialty Radiology
Date 2019 Dec 11
PMID 31821027
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Despite recent advances, cardiovascular disease remains the leading cause of death globally. As such, there is a need to optimise our current diagnostic and risk stratification pathways in order to better deliver individualised preventative therapies. Non-invasive imaging of coronary artery plaque can interrogate multiple aspects of coronary atherosclerotic disease, including plaque morphology, anatomy and flow. More recently, disease activity is being assessed to provide mechanistic insights into atherosclerosis biology. Molecular imaging using positron emission tomography is unique in this field, with the potential to identify specific biological processes using either bespoke or re-purposed radiotracers. This review provides an overview of non-invasive vulnerable plaque detection and molecular imaging of coronary atherosclerosis.

Citing Articles

Chronic Coronary Artery Disease: Wall Disease vs. Lumenopathy.

Paraskevaidis I, Kourek C, Tsougos E Biomolecules. 2025; 15(2).

PMID: 40001504 PMC: 11852618. DOI: 10.3390/biom15020201.


Imaging patients with stable chest pain special feature: introductory editorial.

Oudkerk M, van Beek E Br J Radiol. 2020; 93(1113):20209005.

PMID: 32815396 PMC: 7465861. DOI: 10.1259/bjr.20209005.

References
1.
Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina H . Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study. Circ Cardiovasc Imaging. 2016; 9(12). PMC: 5175997. DOI: 10.1161/CIRCIMAGING.115.004195. View

2.
Adamson P, Dweck M, Newby D . The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues. Heart. 2015; 101(21):1755-66. DOI: 10.1136/heartjnl-2014-307099. View

3.
Kim C, Lee J, Han Y, Chae S, Jin S, Sung C . Glycoprotein IIb/IIIa receptor imaging with F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study. J Nucl Med. 2018; . PMC: 8833852. DOI: 10.2967/jnumed.118.212084. View

4.
Cal-Gonzalez J, Tsoumpas C, Lassen M, Rasul S, Koller L, Hacker M . Impact of motion compensation and partial volume correction for F-NaF PET/CT imaging of coronary plaque. Phys Med Biol. 2017; 63(1):015005. DOI: 10.1088/1361-6560/aa97c8. View

5.
Budoff M, Dowe D, Jollis J, Gitter M, Sutherland J, Halamert E . Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment.... J Am Coll Cardiol. 2008; 52(21):1724-32. DOI: 10.1016/j.jacc.2008.07.031. View